These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22673620)

  • 1. Purinergic signaling and immune cell chemotaxis. Focus on "the UDP-sugar-sensing P2Y14 receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils".
    O'Grady SM
    Am J Physiol Cell Physiol; 2012 Sep; 303(5):C486-7. PubMed ID: 22673620
    [No Abstract]   [Full Text] [Related]  

  • 2. The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.
    Sesma JI; Kreda SM; Steinckwich-Besancon N; Dang H; García-Mata R; Harden TK; Lazarowski ER
    Am J Physiol Cell Physiol; 2012 Sep; 303(5):C490-8. PubMed ID: 22673622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
    Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UDP-sugars activate P2Y
    Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V
    Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of the P2Y14 receptor in human neutrophils.
    Scrivens M; Dickenson JM
    Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
    Abbracchio MP; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA; Burnstock G
    Trends Pharmacol Sci; 2003 Feb; 24(2):52-5. PubMed ID: 12559763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin-promoted release of UDP-glucose from human astrocytoma cells.
    Kreda SM; Seminario-Vidal L; Heusden Cv; Lazarowski ER
    Br J Pharmacol; 2008 Apr; 153(7):1528-37. PubMed ID: 18204471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular UDP-glucose activates P2Y14 Receptor and Induces Signal Transducer and Activator of Transcription 3 (STAT3) Tyr705 phosphorylation and binding to hyaluronan synthase 2 (HAS2) promoter, stimulating hyaluronan synthesis of keratinocytes.
    Jokela TA; Kärnä R; Makkonen KM; Laitinen JT; Tammi RH; Tammi MI
    J Biol Chem; 2014 Jun; 289(26):18569-81. PubMed ID: 24847057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells.
    Katakura S; Takao T; Arase T; Yoshimasa Y; Tomisato S; Uchida S; Masuda H; Uchida H; Tanaka M; Maruyama T
    Placenta; 2020 Nov; 101():194-203. PubMed ID: 33011563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.
    Carter RL; Fricks IP; Barrett MO; Burianek LE; Zhou Y; Ko H; Das A; Jacobson KA; Lazarowski ER; Harden TK
    Mol Pharmacol; 2009 Dec; 76(6):1341-8. PubMed ID: 19759354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation.
    Lecut C; Frederix K; Johnson DM; Deroanne C; Thiry M; Faccinetto C; Marée R; Evans RJ; Volders PG; Bours V; Oury C
    J Immunol; 2009 Aug; 183(4):2801-9. PubMed ID: 19635923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UDP-glucose sensing P2Y
    Zhang JZ; Shi NR; Wu JS; Wang X; Illes P; Tang Y
    Neuropharmacology; 2023 Nov; 238():109655. PubMed ID: 37423482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a carbohydrate recognition motif of purinergic receptors.
    Zhao L; Wei F; He X; Dai A; Yang D; Jiang H; Wen L; Cheng X
    Elife; 2023 Nov; 12():. PubMed ID: 37955640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.
    Scrivens M; Dickenson JM
    Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of P2Y14 receptor in neutrophils promotes inflammation after myocardial ischemia/reperfusion injury.
    Li K; Zhou P; Li J; Cheng Y; Li S; Wang Y; Jiang W; Bai Y; Cao H; Wang D
    Life Sci; 2023 Aug; 326():121805. PubMed ID: 37236604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.
    Bassil AK; Bourdu S; Townson KA; Wheeldon A; Jarvie EM; Zebda N; Abuin A; Grau E; Livi GP; Punter L; Latcham J; Grimes AM; Hurp DP; Downham KM; Sanger GJ; Winchester WJ; Morrison AD; Moore GB
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G923-30. PubMed ID: 19164486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release.
    Idzko M; Panther E; Sorichter S; Herouy Y; Berod L; Geissler M; Mockenhaupt M; Elsner P; Girolomoni G; Norgauer J
    J Cell Physiol; 2004 Nov; 201(2):286-93. PubMed ID: 15334663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.
    Sauzeau V; Le Jeune H; Cario-Toumaniantz C; Vaillant N; Gadeau AP; Desgranges C; Scalbert E; Chardin P; Pacaud P; Loirand G
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1751-61. PubMed ID: 10843869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.
    Hamel M; Henault M; Hyjazie H; Morin N; Bayly C; Skorey K; Therien AG; Mancini J; Brideau C; Kargman S
    J Biomol Screen; 2011 Oct; 16(9):1098-105. PubMed ID: 21821827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.
    Jacob F; Pérez Novo C; Bachert C; Van Crombruggen K
    Purinergic Signal; 2013 Sep; 9(3):285-306. PubMed ID: 23404828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.